HPV-Related Carcinoma Clinical Trials

31 clinical trials for HPV-Related Carcinoma across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer — RECRUITING · PHASE2
• E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers — RECRUITING · PHASE1
• E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers — RECRUITING · PHASE2
• PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer — RECRUITING · PHASE2
• A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC) — RECRUITING · PHASE2
• Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood Collection — RECRUITING · PHASE1
• Detecting HPV DNA in Anal and Cervical Cancers — RECRUITING
• Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC) — RECRUITING
• A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years — RECRUITING · PHASE3
• Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes — RECRUITING · PHASE2
• To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years — RECRUITING · PHASE2
• Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases. — RECRUITING · NA
• Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers — ACTIVE_NOT_RECRUITING · PHASE1
• A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma — COMPLETED · PHASE1
• A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• IBRX-042 In Participants With HPV-Associated Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• HPV Vaccine Effectiveness Study in Rwandan Women Living With HIV — COMPLETED
• A Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC) — ACTIVE_NOT_RECRUITING
• IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma — COMPLETED · PHASE2
• HPV in Blood Samples From Cervical Cancer Patients. — COMPLETED · NA
• A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years — OTHER · PHASE1
• A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males — ACTIVE_NOT_RECRUITING · PHASE3
• Radiosensitivity of HPV-related Tumors: Towards a Genomic Approach — OTHER
• A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years — ACTIVE_NOT_RECRUITING · PHASE3
• A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors — OTHER · PHASE1
• This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols. — TERMINATED
• Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients — WITHDRAWN · PHASE2
• A Tailored, Health Communication Intervention for HPV Vaccine Hesitant Families — OTHER · NA
• Effectiveness and B-memory Cell Response to QHPV Vaccine 9-years Post-vaccination Among HIV-infected Boys and Girls — OTHER
• Integrating Primary & Secondary Interventions for Cervical Cancer Prevention in Primary Care Settings — COMPLETED · NA

Refine this search